Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Derek Rose

Telix posts first profit as sales triple to $502m

Radiation oncology business Telix Pharmaceuticals had a good H1, even though its shares fell. (Steven Saphore/AAP PHOTOS)

Australia's second-biggest biotech company has posted its first-ever profit as its radioactive imaging agent for diagnosing prostate cancer continues to gain market share.

ASX-listed Telix Pharmaceuticals announced on Friday it had made $5.2 million in net profit for the six months to December, compared to a $104 million net loss in the second half of 2022.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.